Download the Info Brief
Navigating Your Path to Globalization: Untangling the Regulatory Maze of the ATMP Supply Chain
Discover expert insights to streamline your path to compliance for the clinical and commercial phases of Advanced Therapy Medicinal Products (ATMPs)
Globalizing your Advanced Therapy Medicinal Products (ATMPs) requires more than just technical know-how—it demands an in-depth understanding of international regulatory frameworks, customs procedures, and risk mitigation strategies.
Partner with Cryoport Systems to take control of your ATMP supply chain. Our end-to-end solutions not only safeguard the integrity of your life-saving therapies but also ensure full regulatory compliance with international standards.
In this Info Brief, you’ll learn how to overcome the complex challenges of scaling your ATMP supply chain internationally. From navigating stringent regulatory requirements in the EMEA region to ensuring compliance with Qualified Person (QP) services, this brief will provide you with the insights and tools you need to ensure that your valuable therapies reach patients safely, compliantly, and efficiently—every step of the way, with a focus on:
- Critical regulatory steps for successful ATMP supply chain management across the EMEA region, including customs clearance and QP services.
- Risk mitigation strategies to safeguard your irreplaceable ATMP shipments through personalized shipping risk assessments and lane qualifications.
- Scalable logistics technologies that offer real-time monitoring and control over your supply chain to ensure safe and compliant transport.